Comparison of computerized provider order entry specific transfusion indications versus the use of “Other”

Author:

Tong Nicholas1ORCID,King Jessica2,Fomani Katayoun12

Affiliation:

1. Department of Pathology and Laboratory Medicine Donald and Barbara Zucker School of Medicine at Northwell Greenvale New York USA

2. Department of Pathology and Laboratory Medicine: Blood Bank Long Island Jewish Medical Center Queens New York USA

Abstract

AbstractBackgroundComputerized physician order entry (CPOE) systems are one way to reinforce evidence‐based transfusion indications for blood products. The new CPOE system that was implemented at our institution allowed healthcare providers to select “Other” as an indication and provide reasons for transfusion outside of accepted guidelines.Study Design and MethodsTransfusion order records for packed red blood cells (RBCs), platelets, and fresh frozen plasma (FFP) from high product‐ordering areas of Long Island Jewish Medical Center and Cohen's Children's Medical Center from April 2021, when the new CPOE system was implemented, to November 2021 were reviewed. The percentage of “Other” orders was determined and the reason for each “Other” order was reviewed to identify possible areas for education or valid indications not included in the institutionally recognized indications.Results9.7% of RBC orders, 1.9% of platelet orders, and 18.2% of FFP orders were placed with “Other” as the indication for transfusion (χ22 = 88.5; p < .001). Reasons for “Other” orders were varied, but notable reasons included indications already institutionally accepted such as, bleeding (15.7% of pediatric “Other” RBC orders), hold for OR (14.3% of pediatric and 15.8% of adult “Other” RBC orders), and novel reasons such as FFP for ACE‐inhibitor associated angioedema (84.6% of adult “Other” FFP orders).DiscussionThe findings from our study provide examples of potential difficulties hospitals may encounter when they implement a new computerized physician order entry system. Provider education may play an important role to reduce the number of “Other” orders placed for already recognized indications.

Publisher

Wiley

Subject

Hematology,Immunology,Immunology and Allergy

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3